Transition report pursuant to Rule 13a-10 or 15d-10

TRANSITION PERIOD COMPARATIVE DATA - Schedule of Selected Interim Reporting Financial Information (Details)

v3.22.4
TRANSITION PERIOD COMPARATIVE DATA - Schedule of Selected Interim Reporting Financial Information (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
9 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Condensed income statement          
Total revenues $ 922,569 $ 897,804 $ 1,185,204 $ 1,178,062  
Total costs and expenses 888,492 867,891 1,158,795 1,181,925  
Loss on impairment (5,187) (24,835) (24,835) (91,260)  
Gain (loss) on disposal of assets (480) 1,388 1,347 (8,199)  
Earnings (losses) from unconsolidated affiliates, net 1,461 (1,413) (1,738) 426  
Operating income (loss) 29,871 5,053 1,183 (102,896)  
Total other income (expense), net (8,792) (8,357) (5,602) 46,256  
Income tax expense (7,494) (8,034) (11,294) 355  
Net loss (income) attributable to noncontrolling interests (57) (141) (78) 191  
Net income (loss) attributable to Bristow Group Inc. $ 13,528 $ (11,479) $ (15,791) $ (56,094)  
Earnings (loss) per common share:          
Basic (in dollars per share) $ 0.48 [1] $ (0.40) $ (0.55) [1] $ 3.12 [1]  
Diluted (in dollars per share) $ 0.47 [1] $ (0.40) $ (0.55) [1] $ 2.32 [1]  
Weighted average shares of common stock outstanding:          
Basic (in shares) 28,066 [1] 28,634 28,533 [1] 24,601 [1]  
Diluted (in shares) 28,574 28,634 28,533 [1] 31,676 [1]  
Condensed cash flows          
Net cash provided by (used in) operating activities $ (13,304) $ 118,277 $ 123,854 $ 96,845  
Net cash used in investing activities (44,142) (9,528) (17,370) 173,274  
Net cash used in financing activities (20,732) (59,592) (63,483) (245,617)  
Effect of exchange rate changes on cash, cash equivalents and restricted cash (24,153) (2,774) (8,066) 7,456  
Net increase (decrease) in cash, cash equivalents and restricted cash (102,331) 46,383 34,935 31,958  
Cash, cash equivalents and restricted cash at beginning of period 266,014 231,079 231,079 199,121  
Cash, cash equivalents and restricted cash at end of period 163,683 277,462 266,014 231,079  
Condensed balance sheets          
Total assets 1,812,001 1,864,789 1,824,279    
Total liabilities 1,025,062 1,020,477 988,911    
Total stockholders’ equity $ 786,939 $ 844,312 $ 835,368 $ 897,071 $ 426,216
[1] See Note 16 to the consolidated financial statements for details on income (loss) per share and weighted average common shares outstanding.